Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Importance Sleep apnea (obstructive and central) is associated with adverse cardiovascular
risk factors and increased risks of cardiovascular disease. Positive airway pressure (PAP) …

Purpose Obstructive sleep apnea (OSA) is suggested to predispose to cardiovascular
disease (CVD) events. It is uncertain whether compliance to continuous positive airway …

Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Rationale: Randomized controlled trials of continuous positive airway pressure (CPAP) in
patients with obstructive sleep apnea (OSA) have not demonstrated protection against …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …